Bone Marrow TransplantationRadiusConsolidation ChemotherapyBone MarrowVasa NervorumBone DensityTransplantation, HomologousAntineoplastic Combined Chemotherapy ProtocolsBone Marrow CellsPeripheral Vascular DiseasesPeripheral Nervous System DiseasesTransplantation, AutologousCytarabineGraft vs Host DiseaseCombined Modality TherapyRemission InductionLeukemia, Myeloid, AcutePeripheral Arterial DiseaseCyclophosphamideTreatment OutcomeHematopoietic Stem Cell TransplantationWhole-Body IrradiationDaunorubicinBone and BonesAntineoplastic AgentsIschemiaEtoposideLeukemia, MyeloidAmputationTransplantation ConditioningSurvival AnalysisAnemia, AplasticLeukemiaDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaIdarubicinLiver TransplantationTransplantation ChimeraAmsacrineChemotherapy, AdjuvantGraft SurvivalBusulfanTissue DonorsMitoxantroneBone Marrow PurgingTime FactorsSurvival RateAcute DiseaseHistocompatibility TestingHematopoietic Stem CellsDrug Administration ScheduleHistocompatibilityBone Marrow DiseasesTransplantation, IsogeneicRecurrenceMice, Inbred C57BLMotion SicknessKidney TransplantationHematopoiesisDoxorubicinFollow-Up StudiesCisplatinPrognosisRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeutropeniaRetrospective StudiesLymphoma, Non-HodgkinBone Marrow ExaminationImmunosuppressive AgentsProspective StudiesHematologic NeoplasmsNeoplasmsGraft RejectionLeukemia, Promyelocytic, AcuteStem Cell TransplantationBreast NeoplasmsHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsT-LymphocytesTransplantation ImmunologyGraft vs Host ReactionImmunosuppressionLymphocyte DepletionLeukocyte TransfusionHeart TransplantationActuarial AnalysisCarmustineMyelodysplastic SyndromesColony-Forming Units AssaySevere Combined ImmunodeficiencyChimeraHLA AntigensMelphalanHematologic DiseasesLung NeoplasmsGranulocyte Colony-Stimulating FactorCells, CulturedCell Differentiation